Delivery Order SPE2DB22D1017-SPE2DB24FF5TA
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, is for the delivery of lidocaine 5% patches. The $1,752.79 firm fixed price delivery order has an ultimate completion date of April 5, 2024. This award is not associated with any set-aside programs. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,819.76 firm fixed-price delivery order is for the supply of 4,567,957,155 units of Lidocaine 5% Patch 30s. The contract has an ultimate completion date of April 18, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,972.80 firm fixed-price contract is for the delivery of 4563926315 - Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,305.19 firm-fixed-price delivery order is for the supply of Lidocaine 5% Patches, which are used for pain management. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,937.47 firm fixed-price delivery order is for the supply of 4560957153 - Lidocaine 5% Patch 30s, with a completion date of May 17, 2023. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,709.61 to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of 4,564,340,251 units of Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,292.52 firm-fixed-price delivery order is for Lidocaine 5% Patches, a topical pain relief medication. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, valued at $4,755.08, is for the delivery of Lidocaine 5% patch 30s, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with an ultimate completion date of April 1, 2024....
- This federal contract award, valued at $13,611.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a prime contractor. The contract is for the delivery of 4564185827 - Lidocaine 5% Patch 30s, a pharmaceutical product, to support military treatment programs and facilities. The contract has a firm fixed price pricing type and a period of performance through April 8, 2024. No set-aside designation was used for this...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Lidocaine 5% Patch 30s. The $1,130.91 contract has an ultimate completion date of April 8, 2024 and does not include any set-aside designation. This delivery order contract is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) that DLA previously awarded to AmerisourceBergen...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF5TADelivery Order
This federal contract award, valued at $4,609.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, and is a firm fixed price delivery order. The contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order was issued under that IDC, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 4/10/24 |